NCT01432730View on ClinicalTrials.gov

A Study to Assess the Efficacy of Gefapixant (MK-7264/AF-219), in Participants With Chronic Cough (MK-7264-006)

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 22, 2011

Primary Completion Date

February 7, 2013

Study Completion Date

February 21, 2013

Conditions
Chronic Cough
Interventions
DRUG

Gefapixant

Oral tablets, BID

DRUG

Placebo

Oral tablets, BID

All Listed Sponsors
lead

Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

INDUSTRY

NCT01432730 - A Study to Assess the Efficacy of Gefapixant (MK-7264/AF-219), in Participants With Chronic Cough (MK-7264-006) | Biotech Hunter | Biotech Hunter